Skip to main content
Clinical Trials/NL-OMON39382
NL-OMON39382CompletedNot Applicable

The assessment of the Plaque at RISK by non-invasive (molecular) imaging and modelling (ParisK): Validation of imaging techniques with histology - ParisK

Medisch Universitair Ziekenhuis Maastricht0 sites71 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
71

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Patients with a carotid artery stenosis, who are scheduled for carotid endarterectomy
  • - age 18 years or older (no maximum age)
  • - informed consent by signing informed consent form regarding this study
  • - inclusion criteria carotid endarterectomy:
  • * symptomatic carotid artery stenosis 70-99% within 3 months of neurologic symptoms
  • * symptomatic carotid artery stenosis 50-99% in man within 2 weeks of neurologic symptoms
  • * asymptomatic carotid artery stenosis 70-99% with contralateral occlusion

Exclusion Criteria

  • * Severe co-morbidity, dementia or pregnancy
  • * Standard contra-indications for MRI (ferromagnetic implants like pacemakers or other electronic implants, metallic eye fragments, vascular clips, claustrophobia, etc.)
  • * Patients who have a documented allergy to MRI or CT contrast media
  • * Patients with a renal clearance <30 ml/min are not eligible to undergo contrast-enhanced MRI
  • * Patients with a renal clearance <60 ml/min are not eligible to undergo dual-energy CT

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Similar Trials